Niquitin Mint (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitin Mint, is a nicotine replacement therapy presented as an oromucosal formulation for oromucosal use. It is intended to aid adults who wish to quit smoking by reducing nicotine withdrawal symptoms.

GNH USA supplies Niquitin Mint as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory‑approved batches to meet global demand.

Niquitin Mint is a nicotine replacement therapy used in the management of nicotine dependence and smoking cessation.

- Smoking cessation: helps adults reduce cravings and withdrawal symptoms when quitting tobacco. - Nicotine dependence: provides controlled nicotine delivery to support gradual reduction of nicotine intake.

Niquitin Mint may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: mild soreness or tingling in the oral cavity. - Nausea: occasional feeling of queasiness. - Headache: mild to moderate head pain. - Dizziness: brief episodes of light‑headedness. - Increased salivation: excess saliva production.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiovascular events: chest pain or palpitations. - Severe nausea/vomiting: persistent and intense gastrointestinal upset. - Hypotension: unusually low blood pressure. - Throat ulceration: painful lesions in the throat.

Before using Niquitin Mint, consider the following precautions to ensure safe and effective use.

- Assess medical history: disclose cardiovascular disease, diabetes, or gastrointestinal disorders. - Avoid use in children: not intended for individuals under the legal smoking age. - Monitor for dependence: prolonged use may lead to nicotine dependence on the product. - Caution with medications: discuss concurrent use of monoamine oxidase inhibitors or other nicotine‑containing products. - Pregnancy and lactation: consult a healthcare professional before use, as safety data are limited. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Niquitin Mint can interact with certain medicines; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): concurrent use may increase risk of hypertensive crisis. - Other nicotine products: combined nicotine exposure can raise the likelihood of cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may enhance nicotine’s effect on mood, requiring monitoring. - Antihypertensive drugs: nicotine can counteract blood‑pressure‑lowering effects. - Caffeine‑containing medications: nicotine may increase stimulant effects, leading to jitteriness.